3-D Matrix Ltd. (7777)

Overview

3-D Matrix, Ltd. is a pioneering company that operates both within Japan and internationally, with a focus on the development of self-assembling peptide technology. This innovative technology finds extensive application in the burgeoning field of regenerative medicine, along with cell therapy, drug delivery systems, and various other industries. Since its inception in 2004, the company has established its headquarters in Tokyo, Japan, positioning itself as a key player in the development of advanced biomaterials.

Products and Services

PuraMatrix: The flagship product of 3-D Matrix, Ltd., PuraMatrix, is at the forefront of their offerings. It is a self-assembling peptide hydrogel that represents a significant advancement in the field of bioengineering and biomaterials. The applications of PuraMatrix are diverse and impactful:

• Regenerative Medicine: In regenerative medicine, PuraMatrix provides a scaffold that facilitates the growth of new tissues by mimicking the body's natural extracellular matrix, thereby aiding in the healing and regrowth of damaged tissues.
• Cell Therapy: For cell therapy, PuraMatrix serves as a delivery vehicle that supports the delivery and growth of therapeutic cells within the body. This application is critical in treatments that involve the restoration of cell function in damaged or diseased tissues.
• Drug Delivery Systems: In drug delivery systems, PuraMatrix offers a unique medium for the controlled release of drugs, enabling targeted therapy with reduced side effects. This application capitalizes on the hydrogel's ability to encapsulate drugs and release them at a controlled rate.

Across these applications, PuraMatrix exemplifies the versatile and transformative potential of self-assembling peptide hydrogels in medicine, showcasing the innovative approach of 3-D Matrix, Ltd. towards solving complex biomedical challenges.